Adil Daud

Angus Chen, a cancer reporter for Stat News, joins oncologist Dr. Adil Daud from UCSF to discuss alarming federal budget cuts affecting cancer research. They explore how slashes to the NIH budget threaten decades of progress in treatment and patient care. Personal anecdotes illustrate the emotional turmoil faced by patients relying on clinical trials, as well as the impact on crucial research initiatives for high-mortality cancers. The conversation emphasizes the need for continued advocacy and funding to sustain vital advancements in cancer treatment.